Kenvue Brands LLC has announced that the FDA has approved the antihistamine Cetirizine Hydrochloride (ZYRTEC HIVES) via BLA NDA019835. This approval strengthens the company’s oral allergy portfolio, leveraging the established efficacy of this 1995-established brand.